(34 days)
AQUARIUS™ Gastrostomy Replacement Tube is intended for use in a well-established gastrostomy tract for feeding and/or administration of medications. May be used for gastric decompression.
Aquariusi Gastrostomy Replacement Tube is a silicone feeding tube comprised of a double lumen tube with external proximal specific ENFit safety access port/s, external retention disk, balloon, and distal open flow-through tip. The tube is with external graduations (cm) and radiopaque marker at the distal end. The tube size and balloon capacity are clearly indicated on the shaft and pouch of each device. The tube is made without use of natural latex, BPA, or phthalates plasticizers.
The provided document is a 510(k) premarket notification for a medical device called the AQUARIUS™ Gastrostomy Replacement Tube. It is a submission to the FDA (Food and Drug Administration) for clearance to market the device, demonstrating substantial equivalence to a legally marketed predicate device.
This document does not describe a study related to the performance of an AI/ML (Artificial Intelligence/Machine Learning) device or a study involving human readers. Therefore, I cannot extract information related to acceptance criteria and studies in the context of AI/ML or human performance improvement.
Instead, the document details the non-clinical summary for the AQUARIUS™ Gastrostomy Replacement Tube, which focuses on device functionality and safety. Here's an analysis of the "acceptance criteria" and "study" in that context:
1. Table of Acceptance Criteria and Reported Device Performance:
The document lists various performance functionality tests conducted on the Gastrostomy Replacement Tube. While specific quantitative acceptance criteria are not explicitly stated in this summary, the completion of these tests implies that the device met pre-defined acceptable limits for each. The "reported device performance" is essentially the successful completion of these tests.
| Acceptance Criteria (Implied) | Reported Device Performance (Implied) |
|---|---|
| Positive pressure liquid leak (within limits) | Test conducted and passed |
| Stress Cracking (within limits) | Test conducted and passed |
| Resistance to separation from axial load (within limits) | Test conducted and passed |
| Resistance to separation from unscrewing (within limits) | Test conducted and passed |
| Resistance to overriding (within limits) | Test conducted and passed |
| Disconnection by unscrewing (within limits) | Test conducted and passed |
| Flow rate (within specifications) | Test conducted and passed |
| Dimension verification (within specifications) | Test conducted and passed |
| Tensile strength (within specifications) | Test conducted and passed |
| Tensile strength of connections (10Fr) (within specifications) | Test conducted and passed |
| Leak Test for G-tube 10F (within limits) | Test conducted and passed |
| Simulated Gastric fluids for G-tube 10Fr (no adverse effects) | Test conducted and passed |
| Balloon burst volume for G-tube 10Fr (within specifications) | Test conducted and passed |
| Biocompatibility (acceptable) | Evaluation conducted and passed |
| Shelf life (3 years) (met) | Test conducted and passed for 3 years shelf life |
2. Sample size used for the test set and the data provenance: Not applicable. This refers to physical device testing, not a dataset. The "test set" would be the specific physical samples of the device used for each test. The provenance is the manufacturer (Degania Silicone, Ltd. in Israel).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. This is for physical device testing, not expert-adjudicated data.
4. Adjudication method for the test set: Not applicable. This refers to physical device testing, not expert-adjudicated data.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This document is for a medical device (gastrostomy tube), not an AI/ML system.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This document is for a medical device (gastrostomy tube), not an AI/ML system.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): The "ground truth" for these non-clinical tests is established by industry standards, international standards (like ISO 14971:2012 for risk management), and internal engineering specifications for the device's physical and functional performance. It's based on objective, measurable parameters and established engineering principles, not expert consensus or clinical outcomes data in the usual sense.
8. The sample size for the training set: Not applicable. This document is for a medical device (gastrostomy tube), not an AI/ML system. There is no concept of a "training set" for physical device testing.
9. How the ground truth for the training set was established: Not applicable. As there's no training set, there's no ground truth to establish for it in this context.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of a human figure, with three faces in profile. The figure is stylized and appears to be in motion.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 29, 2014
Degania Silicone, Ltd. Zoya Lee RA CO Degania Bet Emek Hayarden, 151300 Israel
Re: K143378
Trade/Device Name: AQUARIUS™ Gastrostomy Replacement Tube Regulation Number: 21 CFR 876.5980 Regulation Name: Gastrointestinal Tube and Accessories Regulatory Class: Class II Product Code: PIF Dated: November 12, 2014 Received: November 25, 2014
Dear Zoya Lee,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
{1}------------------------------------------------
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Benjamin R. Fisher -A
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K143378
Device Name AQUARIUSTM Gastrostomy Replacement Tube
Indications for Use (Describe)
AQUARIUS™ Gastrostomy Replacement Tube is intended for use in a well-established gastrostomy tract for feeding and/or administration of medications. May be used for gastric decompression.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Premarket Notification Summary under 21 CFR § 807.92
- a) Type of 510(k) submission: Special
- b) Common name: Gastrostomy Replacement Tube
- c) Device trade name: AQUARIUSi Gastrostomy Replacement Tube
- d) Classification Panel: 21 CFR 876.5980
- e) Classification Name: Gastrointestinal tube and accessories
- f) Class: Il
- g) Product code: PIF
- h) Predicate / Unmodified device: 510(k) K070124
- i) Reference device: 510(k) K141753
- j) 510(k) submitter/holder: Degania Silicone Ltd
- k) FDA Registration Number: 8030107
- Contact person: Zoya Lee, Regulatory Affairs, e-mail: zoya@ds-il.com, fax: +972 4 675 I) 5155, tel: +972 4 6755122
- m) Device Description: Aquariusi Gastrostomy Replacement Tube is a silicone feeding tube comprised of a double lumen tube with external proximal specific ENFit safety access port/s, external retention disk, balloon, and distal open flow-through tip. The tube is with external graduations (cm) and radiopaque marker at the distal end. The tube size and balloon capacity are clearly indicated on the shaft and pouch of each device. The tube is made without use of natural latex, BPA, or phthalates plasticizers.
- n) Indication of Use. Aquariusi Gastrostomy Replacement Tube is indicated for use in a well-established gastrostomy tract for feeding and/or administration of medications. May be used for gastric decompression.
- o) Technological Characteristic. Aquariusi Gastrostomy Replacement Tube is a substantially equivalent to the predicate unmodified device, 510(k) K070124. The difference between modified and unmodified/ predicate device is in the specific ENFit access port/s attached to the funnel of the unmodified device and an addition of the 10Fr size device. The design, materials, performance and safety characteristic of this specific ENFit port/s are the same as the enteral specific connection access port of the reference device 510(k) K141753.
{4}------------------------------------------------
- p) Non- clinical Summary. Non- clinical verification of Aquariusï Gastrostomy Replacement Tube was conducted through the risk management process According to ISO 14971:2012 and performance functionality testing. The following performance testing was conducted on the Gastrostomy Replacement Tube:
-
Positive pressure liquid leak
-
Stress Cracking
-
Resistance to separation from axial load
-
Resistance to separation from unscrewing
-
Resistance to overriding
-
Disconnection by unscrewing
-
Flow rate
-
Dimension verification
- ✔ Tensile strength
-
Tensile strength of the connections of G-tube 10Fr
-
Leak Test for G-tube 10F
- ✔ Simulated Gastric fluids for G-tube 10Fr
-
Balloon burst volume for G-tube 10Fr
-
Biocompatibility evaluation
- ✔ Shelf . life (3 years).
-
§ 876.5980 Gastrointestinal tube and accessories.
(a)
Identification. A gastrointestinal tube and accessories is a device that consists of flexible or semi-rigid tubing used for instilling fluids into, withdrawing fluids from, splinting, or suppressing bleeding of the alimentary tract. This device may incorporate an integral inflatable balloon for retention or hemostasis. This generic type of device includes the hemostatic bag, irrigation and aspiration catheter (gastric, colonic, etc.), rectal catheter, sterile infant gavage set, gastrointestinal string and tubes to locate internal bleeding, double lumen tube for intestinal decompression or intubation, feeding tube, gastroenterostomy tube, Levine tube, nasogastric tube, single lumen tube with mercury weight balloon for intestinal intubation or decompression, and gastro-urological irrigation tray (for gastrological use).(b)
Classification. (1) Class II (special controls). The barium enema retention catheter and tip with or without a bag that is a gastrointestinal tube and accessory or a gastronomy tube holder accessory is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I (general controls) for the dissolvable nasogastric feed tube guide for the nasogastric tube. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.